Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition
- PMID: 2846987
Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition
Abstract
Evidence was sought for the transfer from mother to infant mouse of influenza-specific immunity other than that associated with haemagglutination inhibition (HI) specific antibody. Data were analysed for infant mice born to three groups of mothers: influenza immunized mothers with high levels of HI antibody. influenza immunized mothers in whom influenza-specific HI antibody was suppressed to undetectable levels by passive administration of antibody prior to influenza immunization, and non-immunized control mothers. At 4 weeks of age, infants were given either a lethal or a non-lethal influenza challenge. After a lethal influenza challenge, infants of immunized mothers with HI antibody showed no mortality. Infants of immunized mothers in whom HI antibody was suppressed showed a mortality of 8 to 33%, which was significantly lower than the 71% mortality found in infants of non-immunized control mothers (P less than 0.001). The lower mortality in infants of immunized mothers without HI antibody appeared to be associated with breast feeding, but could not be attributed to the transfer from mother to infant of a local immune response, an influenza specific cytotoxic response, or a secondary antibody response after non-lethal influenza infection. When sera were additionally tested for anti-influenza IgG by ELISA, this lower mortality was found to correlate with anti-influenza serum IgG measurable by ELISA but not detectable by HI. Protective immunity in infants undetectable by HI could be attributable to very low levels of antibody detected by more sensitive ELISA.
Similar articles
-
Maternal-infant transfer of influenza-specific immunity in the mouse.J Immunol. 1983 Feb;130(2):932-6. J Immunol. 1983. PMID: 6848601
-
Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines.Immunology. 1987 Jan;60(1):83-9. Immunology. 1987. PMID: 3817868 Free PMC article.
-
Assessment of resistance to influenza virus infection in animal models.Dev Biol Stand. 1975;28:307-18. Dev Biol Stand. 1975. PMID: 1126574
-
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.Eur J Immunol. 1984 Apr;14(4):350-6. doi: 10.1002/eji.1830140414. Eur J Immunol. 1984. PMID: 6609824
-
Influenza prevention and treatment by passive immunization.Acta Biochim Pol. 2014;61(3):573-87. Epub 2014 Sep 12. Acta Biochim Pol. 2014. PMID: 25210721 Review.
Cited by
-
Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.BMC Infect Dis. 2007 Oct 16;7:118. doi: 10.1186/1471-2334-7-118. BMC Infect Dis. 2007. PMID: 17939857 Free PMC article.
-
An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species.Arch Virol. 1990;115(1-2):47-61. doi: 10.1007/BF01310622. Arch Virol. 1990. PMID: 2174233
-
Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization.Virol J. 2017 Jun 26;14(1):123. doi: 10.1186/s12985-017-0787-4. Virol J. 2017. PMID: 28651593 Free PMC article.
-
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.J Virol. 1990 Mar;64(3):1370-4. doi: 10.1128/JVI.64.3.1370-1374.1990. J Virol. 1990. PMID: 2304146 Free PMC article.